Normalisation of NLR improved median OS from 9.4 months (cohort 2; 95% CI 3.2–15.5) to 12.1 months (cohort 3; 95% CI 7.3–16.8) in patients with a persistently elevated NLR, although this did not reach statistical significance ( P -level 0.053; Figure 3B ).
← all excerpts
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.
1
—
—